secwatch.observer — SEC 8-K summary
======================================

Issuer:     AEON Biopharma, Inc. (AEON)
CIK:        0001837607
Form:       8-K
Filed at:   2023-02-10T23:59:59+00:00
Accession:  0001104659-23-018664
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 3.03, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Priveterra extends business combination deadline to Aug 11, 2023; ~$258.8M redeemed
--------------------------------------------------------------------------------

- Shareholders approved extending the business combination deadline from Feb 11, 2023 to Aug 11, 2023.
- Approval vote: 24,548,209 for, 3,245,246 against, with 2,463 abstentions.
- Holders of 25,597,728 shares redeemed at ~$10.11/share for aggregate ~$258.8 million.
- Redemption represents approximately 74% of total outstanding shares (based on 34.5M shares outstanding).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1837607/000110465923018664/0001104659-23-018664-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1837607/000110465923018664/tm236357d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-018664

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer